Effect of diaspirin cross-linked hemoglobin on endothelin-1 and blood pressure in acute ischemic stroke in man

Journal of Hypertension

Volumn 16, Issue 10, 1998, Pages 1459-1465

  Saxena, Ritu ^a   Wijnhoud, Annemarie D ^a   Man In 'T Veld, Arie J ^a   Van Den Meiracker, Anton H ^a   Boomsma, Frans ^a   Przybelski, Robert J ^b   Koudstaal, Peter J ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b BAXTER HEALTHCARE CORPORATION   (United States)

Author keywords

Acute ischemic stroke; Blood pressure; Blood substitute; Diaspirin cross linked hemoglobin; Endothelin 1

Indexed keywords

ADRENALIN; ATRIAL NATRIURETIC FACTOR; CATECHOLAMINE DERIVATIVE; DCLHB; ENDOTHELIN 1; HEMOGLOBIN DERIVATIVE; NORADRENALIN; RENIN; SALICYLIC ACID DERIVATIVE; UNCLASSIFIED DRUG; VASOPRESSIN;

ADRENALIN BLOOD LEVEL; ADULT; AGED; ARTICLE; BLOOD PRESSURE; CATECHOLAMINE BLOOD LEVEL; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSS LINKING; DOSE RESPONSE; DOSE TIME EFFECT RELATION; FEMALE; HEART RATE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; MEAN ARTERIAL PRESSURE; NORADRENALIN BLOOD LEVEL; PHASE 2 CLINICAL TRIAL; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VASOPRESSIN BLOOD LEVEL;

EID: 0031656086     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-199816100-00009     Document Type: Article

References (41)

1. Przybelski RJ, Daily EK, Kisicki JC, Mattia-Goldberg C, Bounds MJ, Colburn WA. Phase I study of the safety and pharmacologic effects of diaspirin cross-linked hemoglobin solution. Crit Care Med 1996; 24:1993-2000.
2. Amberson WR, Jennings JJ, Rhode C. Clinical experience with hemoglobin-saline solutions. J Applied Physiol 1949; 1:469-489.
3. Gibaldi M. What is nitric oxide and why are so many people studying it? J Clin Pharmacol 1993; 33:488-496.
4. Schultz SC, Grady B, Cole F, Hamilton I, Burhop K, Malcolm DS. A role for endothelin and nitric oxide in the pressor response to diaspirin cross-linked hemoglobin. J Lab Clin Med 1993; 122:301-308.
5. Cocks TM, Malta E, King SJ, Woods RL, Angus JA. Oxyhaemoglobin increases the production of endothelin-1 by endothelial cells in culture. Eur J Pharmacol 1991; 196:177-182.
6. Ohlstein EH, Storer BL. Oxyhemoglobin stimulation of endothelin production in cultured endothelial cells. J Neurosurg 1992; 77:274-278.
7. Gulati A, Sharma AC, Singh G. Role of endothelin in the cardiovascular effects of diaspirin crosslinked and stroma reduced hemoglobin. Crit Care Med 1996; 24:137-147.
8. Nanavaty M, Scanlan DM, McKenzie J. Diaspirin cross-linked hemoglobin characterization of blood pressure response in swine [abstract]. In: Vth International Symposium on Blood Substitutes, Program and Abstracts, March 17-20, 1993. San Diego, California: TMS Chang, University of California at San Diego; 1993.
9. Azari M, Rohn K, Picken J. Diaspirin crosslinked hemoglobin (DCLHb): characterization of the process and the product manufactured under GMP requirements for clinical studies. Artif Cells Blood Substit Immobil Biotechnol 1994; 22:701-708.
10. Cole DJ, Schell RM, Przybelski RJ, Drummond JC, Bradley K. Focal cerebral ischemia in rats: effect of hemodilution with alpha-alpha cross-linked hemoglobin on CBF. J Cereb Blood Flow Metab 1992; 12:971-976.
11. Cole DJ, Schell RM, Drummond JC, Pryzbelski PJ, Marcantonio S. Focal cerebral ischemia in rats: effect of hemodilution with alpha-alpha cross-linked hemoglobin on brain injury and edema. Can J Neurol Sci 1993; 20:30-36.
12. Bowes MP, Burhop KE, Zivin JA. Diaspirin cross-linked hemoglobin improves neurological outcome following reversible but not irreversible CNS ischemia in rabbits. Stroke 1994; 25:2253-2257.
13. Cole DJ, Nary JC, Drummond JC, Patel PM, Jacobsen WK. Alpha-alpha diaspirin crosslinked hemoglobin, nitric oxide, and cerebral ischemic injury in rats. Artif Cells Blood Substit Immobil Biotechnol 1997; 25:141-152.
14. van Swieten JC, Koudstaal PJ, Visser MC, Schouten HJ, van Gijn J. Interobserver agreement for the assessment of handicap in stroke patients. Stroke 1988; 19:604-607.
15. van der Hoorn FA, Boomsma F, Man in 't Veld A, Schalekamp MA. Determination of catecholamines in human plasma by high-performance liquid chromatography: comparison between a new method with fluorescence detection and an established method with electrochemical detection. J Chromatogr 1989; 487:17-28.
16. Boomsma F, Bhaggoe UM, Man in 't Veld A, Schalekamp MA. Comparison of N-terminal pro-atrial natriuretic peptide and atrial natriuretic peptide in human plasma as measured with commercially available radioimmunoassay kits. Clin Chim Acta 1996; 252:41-49.
17. Bhaggoe UM, Boomsma F, Admiraal PJ, Man in 't Veld A, Schalekamp MA. Stability of human plasma atrial natriuretic peptide during storage at -80 degrees C. Clin Chim Acta 1993; 223:179-184.
18. Derkx FH, Tan-Tjiong L, Wenting GJ, Boomsma F, Man in 't Veld A, Schalekamp MA. Asynchronous changes in prorenin and renin secretion after captopril in patients with renal artery stenosis. Hypertension 1983; 5:244-256.
19. Wallace JD, Levy LL. Blood pressure after stroke. JAMA 1981; 246:2177-2180.
20. Britton M, Carlsson A, de Faire U. Blood pressure course in patients with acute stroke and matched controls. Stroke 1986; 17:861-864.
21. Jansen PA, Schulte BP, Poels EF, Gribnau FW. Course of blood pressure after cerebral infarction and transient ischemic attack. Clin Neurol Neurosurg 1987; 89:243-246.
22. Carlberg B, Asplund K, Hagg E. Factors influencing admission blood pressure levels in patients with acute stroke. Stroke 1991; 22:527-530.
23. Harper G, Castleden CM, Potter JF. Factors affecting changes in blood pressure after acute stroke. Stroke 1994; 25:1726-1729.
24. Miller RC, Pelton JT, Huggins JP. Endothelins: from receptors to medicine. Trends Pharmacol Sci 1993; 14:54-60.
25. Gulati A, Singh R, Chung SM, Sen AP. Role of endothelin-converting enzyme in the systemic hemodynamics and regional circulatory effects of proendothelin-1 (1-38) and diaspirin cross-linked hemoglobin in rats. J Lab Clin Med 1995; 126:559-570.
26. Sorensen SS, Madsen JK, Pedersen EB. Systemic and renal effect of intravenous infusion of endothelin-1 in healthy human volunteers. Am J Physiol 1994; 266:F411-F418.
27. Kaasjager KA, Koomans HA, Rabelink TJ. Endothelin-1-induced vasopressor responses in essential hypertension. Hypertension 1997; 30:15-21.
28. Lerman A, Hildebrand FLJ, Aarhus LL, Burnett JCJ. Endothelin has biological actions at pathophysiological concentrations. Circulation 1991; 83:1808-1814.
29. Cannan CR, Burnett JCJ, Brandt RR, Lerman A. Endothelin at pathophysiological concentrations mediates coronary vasoconstriction via the endothelin-A receptor. Circulation 1995; 92:3312-3317.
30. Toothill C. The chemistry of the in vivo reaction between hemoglobin and various oxides of nitrogen. Br J Anaesth 1967; 39:405-412.
31. Benesch RE, Benesch R, Yung S. Equations for the spectrophotometric analysis of hemoglobin mixtures. Anal Biochem 1973; 55:245-248.
32. Banting J, Friberg P, Adams M. Acute hypertension after nitric oxide synthase inhibition is mediated primarily by increased endothelin vasoconstriction. J Hypertens 1996; 14:975-981.
33. Kourembanas S, McQuillan LP, Leung GK, Faller DV. Nitric oxide regulates the expression of vasoconstrictors and growth factors by vascular endothelium under both normoxia and hypoxia. J Clin Invest 1993; 92:99-104.
34. Richard V, Hogie M, Clozel M, Loffler BM, Thuillez C. In vivo evidence of an endothelin-induced vasopressor tone after inhibition of nitric oxide synthesis in rats. Circulation 1995; 91:771-775.
35. Florijn KW, Derkx FH, Visser W, Hofman JA, Rosmalen FM, Wallenburg HC, et al. Plasma immunoreactive endothelin-1 in pregnant women with and without pre-eclampsia. J Cardiovasc Pharmacol 1991; 17 (suppl 7):S446-S448.
36. Hasdai D, Kornowski R, Battler A. Endothelin and myocardial ischemia. Cardiovasc Drugs Ther 1994; 8:589-599.
37. Estrada V, Tellez MJ, Moya J, Fernandez-Durango R, Egido J, Fernandez CA. High plasma levels of endothelin-1 and atrial natriuretic peptide in patients with acute ischemic stroke. Am J Hypertens 1994; 7:1085-1089.
38. Ziv I, Fleminger G, Djaldetti R, Achiron A, Melamed E, Sokolovsky M. Increased plasma endothelin-1 in acute ischemic stroke. Stroke 1992; 23:1014-1016.
39. Lampl Y, Fleminger G, Gilad R, Galron R, Sarova-Pinhas I, Sokolovsky M. Endothelin in cerebrospinal fluid and plasma of patients in the early stage of ischemic stroke. Stroke 1997; 28:1951-1955.
40. Wieczorek I, Haynes WG, Webb DJ, Ludlam CA, Fox KA. Raised plasma endothelin in unstable angina and non-Q wave myocardial infarction: relation to cardiovascular outcome. Br Heart J 1994; 72:436-441.
41. McMurray JJ, Ray SG, Abdullah I, Dargie HJ, Morton JJ. Plasma endothelin in chronic heart failure. Circulation 1992; 85:1374-1379.